Knowledge graph · Variant
ALK Fusion
fusion
- Identifier
- CI-VAR-00001179
- Entity page
- /variant/v-alk-fusion ↗
- Edges
- 30
- Neighbours
- 10 cancers8 drugs
- Drawn
- 18 of 18 neighbours (cap 60); table lists every fetched edge
Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.
Most connectedLung Non-Small Cell Carcinoma 3,149Malignant Colorectal Neoplasm 1,866ABL1 298EGFR 276Imatinib 450Dasatinib 321
Neighbourhood
Radial view
Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.
Edges
Every edge, grouped by relationship
Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.
| Relationship | Neighbour | Direction | Evidence level | Cancer context | Support | Claim | Source | Expand |
|---|---|---|---|---|---|---|---|---|
| ALK Fusion predicts response to …PREDICTS_RESPONSE_TO15 of 19show all (up to 200) | ||||||||
| → predicts response to | Crizotinibsmall_molecule 5 source records aggregated | sensitivity | A | Anaplastic Large Cell Lymphoma,Inflammatory Myofibroblastic Tumor,Lung Non-Small Cell Carcinoma | 5 | Curated | civic | |